Evidence map›Paper›PMID 33031511›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Epidemiological Trends of Racial Differences in Early- and Late-onset Group B Streptococcus Disease in Tennessee.

Lubna Hamdan, Simon Vandekar, Andrew J Spieker, Herdi Rahman, Danielle Ndi, Emily S Shekarabi, Jyotsna Thota, Danielle A Rankin, Zaid Haddadin, Tiffanie Markus and 4 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Lubna HamdanDepartment of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Simon VandekarDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Andrew J SpiekerDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Herdi RahmanDepartment of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Danielle NdiDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Emily S ShekarabiDepartment of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jyotsna ThotaDepartment of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Danielle A RankinDepartment of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Zaid HaddadinDepartment of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Tiffanie MarkusDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
David M AronoffDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
William SchaffnerDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jennifer A GaddyDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Natasha B HalasaDepartment of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · USVA Tennessee Valley Healthcare System · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
NRSA Training CoreTL1TR002244 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$4.6M
Repurposing misoprostol to prevent recurrence of Clostridium difficile infectionU01TR002398 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DOSTER, RYAN S, DUBBERKE, ERIK R · 2018 to 2019
$3.1M
Determining the contribution of zinc deficiency to perinatal Group B Streptococcus infectionsR01HD090061 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ARONOFF, DAVID M, GADDY, JENNIFER A · 2017 to 2021
$2.5M
The Role of macrophages in chorioamnionitis and group B streptococcal infectionsR01AI134036 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ARONOFF, DAVID M · 2017 to 2021
$2.4M
Regulation of Helicobacter pylori pili encoded by the cag pathogenicity islandIK2BX001701 · VA · VETERANS HEALTH ADMINISTRATION · PI GADDY, JENNIFER A · 2013 to 2017
–
BLRD VA IK2 BX001701Career Development Award IK2BX001701CDC HHSEmerging Infections Program's 1U50CK000491NCATS NIH HHS TL1 TR002244NCATS NIH HHS U01 TR002398NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR000445-06NCRR NIH HHS UL1 RR024975NCRR NIH HHS UL1 RR024975-01NIAID NIH HHS R01 AI134036NICHD NIH HHS R01 HD090061NIH HHS R01 HD090061REDCap ULI TR000445
6 · The paper itself

Abstract

backgroundThe rates of early-onset group B Streptococcus (GBS) disease (EOGBS) have declined since the implementation of universal screening and intrapartum antibiotic prophylaxis guidelines but late-onset (LOGBS) rates remain unchanged. Racial differences in GBS disease rates have been previously documented, with Black infants having higher rates of EOGBS and LOGBS, but it is not known if these have persisted. Therefore, we sought to determine the differences in EOGBS and LOGBS disease by race over the past decade in Tennessee.

methodsThis study used active population-based and laboratory-based surveillance data for invasive GBS disease conducted through Active Bacterial Core surveillance in selected counties across Tennessee. We included infants younger than 90 days and who had invasive GBS disease between 2009 and 2018.

resultsA total of 356 GBS cases were included, with 60% having LOGBS. EOGBS and LOGBS had decreasing temporal trends over the study period. Overall, there were no changes in temporal trend noted in the rates of EOGBS and LOGBS among White infants. However, Black infants had significantly decreasing EOGBS and LOGBS temporal trends (relative risk [95% confidence interval], .87 [.79, .96] [P = .007] and .90 [.84-.97] [P = .003], respectively).

conclusionsYears after the successful implementation of the universal screening guidelines, our data revealed an overall decrease in LOGBS rates, primarily driven by changes among Black infants. More studies are needed to characterize the racial disparities in GBS rates, and factors driving them. Prevention measures such as vaccination are needed to have a further impact on disease rates.

Indexed as

Pregnancy Complications, InfectiousStreptococcal InfectionsAntibiotic ProphylaxisFemaleHumansInfantInfectious Disease Transmission, VerticalPregnancyRace FactorsStreptococcus agalactiaeTennesseeearly-onsetgroup B Streptococcuslate-onsetrace

Identifiers

PMID33031511
PMCPMC8662779
OpenAlexW3092543360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.